Back to search

National and Kapodistrian University of Athens

Μελέτες δομής και αυτοσυγκρότησης αμυλοειδογόνων πρωτεϊνών ή τμημάτων τους που σχετίζονται με αμυλοειδώσεις

Abstract

dc:description

Under pathological conditions, a large number of otherwise soluble proteins may fail to maintain their normal three-dimensional structure and thus, may undergo general or partial refolding of their polypeptide chains. Misfolded protein molecules may subsequently self-assemble into either amorphous or ordered protein aggregates, which share distinctive structural and tinctorial properties and are commonly called amyloid fibrils. Wild type or mutated amyloidogenic proteins, are transferred and deposited in different organs and/or tissues, either as extracellular accumulations (amyloid plaques) or as insoluble inclusion bodies. In any case, amyloid fibrils have been linked to the development of a broad class of diseases, called amyloidoses. Striking examples of this class are the neurodegenerative Alzheimer’s and Parkinson’s disease, prion diseases and other disorders, such as diabetes type II or a broad number of carcinomas. Overall, amyloidogenic proteins belong to a diverse group of macromolecules, displaying significant sequence and structural differences. At least, 35 human proteins are found to form pathological amyloid deposits in tissues, while this feature was associated with several mutations and/or microenvironment changes that lead to protein misfolding. The group of amyloidogenic proteins is constantly enriched with proteins that are found to form amyloid fibrils in vitro and surprisingly, have never been previously related with amyloidoses.Aiming at deciphering the molecular mechanisms, underlying amyloid fibril formation, in this thesis, A) we carried out a systematic /computational analysis on the diverse set of amyloidogenic proteins and also B) we performed targeted aggregation experiments on individual proteins, testing their amyloidogenic profile. A) The implication of more than one proteins in the progression of different aggregation disorders, together with the synergistic co-deposition of different amyloidogenic proteins in amyloid plaques of patients, highlights the necessity for a more universal approach, during the study of these proteins. In an attempt to address this pivotal need we constructed and analyzed a protein-protein interaction network of amyloidogenic proteins and their experimentally verified interactors, based on the complex network theory analysis. The Amyloid Interactome 1) gathers a group of heterogeneous proteins into a common biological interaction network, 2) assembles all known interconnections between well-characterized amyloidogenic proteins and proteins related to amyloid fibril formation and 3) unravels functional roles of all its constituent elements. To our knowledge, this integrated approach points to a new picture on protein aggregation and introduces for the first time a comprehensive protein map of amyloidogenicity. Eventually, Amyloid Interactome is expected to assist the development of novel therapeutic strategies in protein aggregation diseases.B) In this thesis, targeted aggregation experiments were focused on individual human proteins with a known or unexplored, until now, amyloidogenic profile. Α key milestone in the history of amyloid research was the idea that amyloid formation may be an inherent ability of proteins, under specific conditions. Appropriate biophysical methodologies are commonly used to record all distinct morphological and structural features of fibrillar structures that are either in in vivo or in in vitro aggregation assays.Under the right conditions, many proteins expose fibril-forming segments, which may be sufficient to cause aggregation and fibril formation. Following this idea, we turned our interest into small ‘aggregation-prone’ regions, which are considered responsible for the polymerization of proteins, associated with amyloidoses. In this thesis, short sequence stretches, named amyloidogenic determinants, were computationally identified and experimentally evaluated, utilizing several biophysical techniques (transmission electron microscopy, X-ray diffraction, polarizing microscopy, IR spectroscopy), whereas experimental results were combined in order to let us propose plausible polymerization models of each protein system.Experimental studies on known amyloidogenic proteins: -The oligomerization of human cystatin C is involved in the pathophysiology of a rare form of amyloidosis namely Icelandic hereditary cerebral amyloid angiopathy. Amyloidogenic proteins like cystatin C have been shown to form dimers and oligomers by exchange of subdomains of the monomeric proteins. In this work, in order to find the shortest stretch responsible to drive the fibril formation of cystatin C, we revealed that three ‘aggregation-prone’ segments of the protein self-assemble into typical amyloid fibrils and might be active ingredients of cystatin C aggregation. Based on these results, we also demonstrated two plausible self-aggregation pathways, which prove the fundamental contribution of all three peptides in forming the ‘aggregation-prone’ core of human cystatin C.-The rapid aggregation of amylin is implicated in the pathology of diabetes type II. Although the entire sequence of human amylin has been denoted as amyloidogenic, literature data reveal that both the N- and C-terminal of amylin were excluded from any aggregation study. Incomplete knowledge on the aggregation potency of the terminal regions of amylin allowed us to design 3 distinct groups of amyloidogenic determinants, corresponding to N- and C- terminals of amylin. The aggregation properties of each peptide were confirmed by several biophysical techniques, whereas in addition to the self-interactions, cross-amyloid interactions between amylin and separate amyloidogenic determinants were evaluated. Overall, our results offer a novel molecular basis for understanding the contribution of the terminal regions of amylin in the self-assembly of the protein that may prove to be powerful new directions for future therapies to combat the devastating consequences of diabetes.Experimental studies on proteins with unexplored amyloidogenic properties: -Proinsulin C-peptide or C-peptide, a 31 amino acid long molecule, was for several years a forgotten parameter in insulin studies. Much time and effort has been spent in exploring all functional features of C-peptide, only a few studies, though, have addressed C-peptide oligomerization and link this procedure with Diabetes. Early studies of C-peptide self-aggregation stated clearly that C-peptide on its own does not give rise to amyloid fibrils, a finding consistent with the extremely weak amyloidogenic profile of C-peptide. Taking all the above studies into consideration, in the present thesis, we decided to test the propensity of full length C-peptide to self-assemble into amyloid fibrils, in vitro. Our experimental work clearly shows that C-peptide self-assembles into amyloid-like fibrils and therefore, the aggregation propensity of C-peptide is a characteristic novel feature that should be related to physiological and also pathological conditions. A model for amyloid fibril formation for C-peptide, based on the chameleon properties of its sequence, is also provided.-Clusterin is an extracellular, heterodimeric chaperone, which is present in all disease-associated extracellular amyloid deposits. To date, clusterin’s contribution in amyloid formation and protein deposition in vivo is poorly understood. The intrinsically disordered nature of clusterin, together with its ability to specifically interact with a wide range of amyloidogenic molecules has prompted us to thoroughly study its amyloidogenic profile. Computational analysis led us to synthesize and experimentally study five potent amyloidogenic determinants, derived from the clusterin α-chain sequence. Our experimental results revealed that all five peptides self-assemble into amyloid-like fibrils in vitro, fulfilling all amyloid criteria. This fact provides a potent indication that at least the clusterin α-chain intrinsically exhibits amyloidogenicity and may also form amyloid-like fibrils in vitro. This finding also raises the possibility that, at least in some circumstances, amyloidogenic determinants derived from clusterin in vivo could be a therapeutic tool in the fight against protein aggregation disorders.-Stefin A, a molecule evolutionary related to the amyloidogenic cystatin C, follows the same polymerization pathway, even though its role in amyloidosis pathology is still unknown. Stefin A provides an important protective function as an intracellular inhibitor of cysteine proteases. However, it has been suggested that oligomers of stefin A have been detected in several carcinomas. In order to determine the hidden amyloidogenic profile of stefin A, four computationally predicted amyloidogenic determinants were experimentally tested. From this work it is clear that stefin A consists of amyloidogenic regions, which render the polypeptide chain prone to protein aggregation, probablt following a polymerization mechanism analogous to cystatin C.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsiolaki, Paraskevi
  • Τσιολάκη, Παρασκευή

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42866

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsiolaki, Paraskevi; Τσιολάκη, Παρασκευή. Μελέτες δομής και αυτοσυγκρότησης αμυλοειδογόνων πρωτεϊνών ή τμημάτων τους που σχετίζονται με αμυλοειδώσεις. National and Kapodistrian University of Athens, 2018. http://hdl.handle.net/10442/hedi/42866